This post was originally published on this site
The companies are discussing a price of about $39 a share, the newspaper said.
The deal, if it goes through, could be announced as soon as this week, the report added.
CVS and Oak Street Health did not immediately respond to Reuters’ requests for comment.
Bloomberg News reported last month that CVS was exploring a deal for Oak Street Health.
Oak Street Health runs primary care centers across the United States for recipients of Medicare, the U.S. government insurance program for Americans aged 65 and older, and has private equity firms such as General Atlantic and Newlight Partners among its shareholders.
CVS had also expressed interest in expanding into the primary care space, and was reportedly among the bidders to acquire primary care provider Cano Health before backing out.
